https://www.nice.org.uk/guidance/indevelopment/gid-ta11613
Project information | Cabozantinib for treating advanced neuroendocrine tumours that have...
Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474]
project informationneuroendocrine tumourscabozantinibtreatingadvanced
https://www.brunel.ac.uk/IamBrunel/profile?entryId=4f0d3050-6e33-e662-a54e-457db26b116d
Franchise Marketing Intern within Neuroendocrine Tumours and Renal-Cell Carcinoma
Biomedical science placement
franchise marketingneuroendocrine tumoursinternwithinrenal
https://pmc.ncbi.nlm.nih.gov/articles/PMC4952131/
Nuclear medicine imaging of neuroendocrine tumours - PMC
nuclear medicine imagingneuroendocrine tumourspmc
https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/somatostatin-analogues-for-neuroendocrine-tumours-nets
Somatostatin analogues for neuroendocrine tumours (NETs) | Macmillan Cancer Support
Somatostatin analogues (SSAs) are drugs that treat the symptoms of carcinoid syndrome. They can help reduce diarrhoea and flushing whilst slowing tumour growth.
neuroendocrine tumoursmacmillan cancersomatostatinanaloguesnets
https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment/somatostatin-analogue-drugs
Somatostatin analogues for neuroendocrine tumours | Cancer Research UK
Somatostatin analogues are drugs that stop your body from making too many hormones. They are a possible treatment for some neuroendocrine tumours (NETs).
neuroendocrine tumourscancer researchsomatostatinanaloguesuk
https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment/tae
Trans arterial embolisation (TAE) for neuroendocrine tumours (NETs) | Cancer Research UK
TAE is a treatment for neuroendocrine tumours (NETs) that spread to the liver. It means having a substance such as a gel or tiny beads to block the blood...
neuroendocrine tumourscancer researchtransarterialembolisation
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-lanreotide-autogel-for-neuroendocrine-tumours-of-the-digestive-system-that-have-spread
A trial looking at lanreotide autogel for neuroendocrine tumours of the digestive system that have...
This trial looked at a drug called lanreotide autogel to stop or slow the growth of neuroendocrine tumours (NETs).
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-everolimus-for-neuroendocrine-tumours-of-the-pancreas-oblique
A study looking at everolimus for neuroendocrine tumours of the pancreas (The OBLIQUE study)
This study is to find out more about the drug everolimus (also known Afinitor) as a treatment for neuroendocrine tumours of the pancreas.
a studylooking at
https://www.cancerresearchuk.org/about-cancer/treatment/radioisotopes/131-i-mibg
Radioactive iodine MIBG (131 I-MIBG) for neuroendocrine tumours (NETs) | Cancer Research UK
131 I-MIBG is a type of radioisotope therapy. It uses radioactive iodine attached to a substance called MIBG. It is a possible treatment for NETs.
radioactive iodine
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-the-immune-system-for-people-with-neuroendocrine-tumours-immunet
A study looking at the immune system for people with neuroendocrine tumours (IMMUNET)
This study is trying to understand more about how the immune system works in people with a neuroendocrine tumour (NET).
the immune system
https://www.livingwithnets.com/
Living with NETs: For people with neuroendocrine tumours (NETs)
Jun 27, 2022 - Living with NETs provides information and support for people with neuroendocrine tumours (NETs) from diagnosis to treatment and living with NETs long term.
living with netsfor peopleneuroendocrinetumours
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-of-lanreotide-for-neuroendocrine-tumours-of-the-pancreas-or-small-bowel-that-have-spread
A study of lanreotide for neuroendocrine tumours of the pancreas or small bowel that have spread...
This study is for people with a neuroendocrine tumour that started in the pancreas or small bowel (duodenum) and cannot be removed with surgery.